{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T22:18:07Z","timestamp":1774736287406,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.ejogrb.2013.03.002","type":"journal-article","created":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T07:48:16Z","timestamp":1364456896000},"page":"244-247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Advantages of recombinant follicle-stimulating hormone over human menopausal gonadotropin for ovarian stimulation in intrauterine insemination: a randomized clinical trial in unexplained infertility"],"prefix":"10.1016","volume":"169","author":[{"given":"Mandana","family":"Rashidi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashraf","family":"Aaleyasin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzieh","family":"Aghahosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohre","family":"Loloi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abas","family":"Kokab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Najmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2013.03.002_bib0005","series-title":"Clinical gynecologic endocrinology and infertility","author":"Fritz","year":"2011"},{"key":"10.1016\/j.ejogrb.2013.03.002_bib0010","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/humupd\/dmh044","article-title":"Historical perspectives in gonadotrophin therapy","volume":"10","author":"Lunenfeld","year":"2004","journal-title":"Human Reproduction Update"},{"key":"10.1016\/j.ejogrb.2013.03.002_bib0015","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1472-6483(10)61155-8","article-title":"Are recombinant gonadotropins safer, purer and more effective than urinary gonadotropins?","volume":"11","author":"Casper","year":"2005","journal-title":"Reproductive Biomedicine Online"},{"key":"10.1016\/j.ejogrb.2013.03.002_bib0020","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.fertnstert.2008.08.031","article-title":"Practice committee of the American society for reproductive medicine gonadotropin preparations: past, present, and future perspectives","volume":"90","year":"2008","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2013.03.002_bib0025","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1093\/oxfordjournals.humrep.a138440","article-title":"Composition of commercial gonadotrophin preparations extracted from human postmenopausal urine: characterization of non-gonadotrophin proteins","volume":"9","author":"Giudice","year":"1994","journal-title":"Human Reproduction"},{"key":"10.1016\/j.ejogrb.2013.03.002_bib0030","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0015-0282(03)00594-6","article-title":"Comparison of controlled ovarian stimulation with human menopausal gonadotropin or recombinant follicle-stimulating hormone","volume":"80","author":"Filicori","year":"2003","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2013.03.002_bib0035","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1093\/humrep\/del284","article-title":"Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial","volume":"21","author":"Andersen","year":"2006","journal-title":"Human Reproduction"},{"key":"10.1016\/j.ejogrb.2013.03.002_bib0040","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3109\/00016349.2010.499450","article-title":"Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing their first treatment cycle of IVF or ICSI","volume":"89","author":"Bjercke","year":"2010","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1016\/j.ejogrb.2013.03.002_bib0045","first-page":"733","article-title":"Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques","volume":"49","author":"Cheon","year":"2004","journal-title":"Journal of Reproductive Medicine"},{"key":"10.1016\/j.ejogrb.2013.03.002_bib0050","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1093\/humrep\/den220","article-title":"Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists-a randomized study","volume":"23","author":"Bosch","year":"2008","journal-title":"Human Reproduction"},{"key":"10.1016\/j.ejogrb.2013.03.002_bib0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/humrep\/del335","article-title":"Comparison of different gonadotrophin preparations in intrauterine insemination cycles for the treatment of unexplained infertility: a prospective, randomized study","volume":"22","author":"Demirol","year":"2007","journal-title":"Human Reproduction"},{"key":"10.1016\/j.ejogrb.2013.03.002_bib0060","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/09513591003632175","article-title":"Lyophilised hMG versus rFSH in women with unexplained infertility undergoing a controlled ovarian stimulation with intrauterine insemination: a prospective, randomized study","volume":"26","author":"Kocak","year":"2010","journal-title":"Gynecological Endocrinology"},{"key":"10.1016\/j.ejogrb.2013.03.002_bib0065","series-title":"WHO laboratory manual for the examination of human semen and semen-cervical mucus interaction","author":"World Health Organization","year":"1992"},{"key":"10.1016\/j.ejogrb.2013.03.002_bib0070","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0015-0282(16)57556-6","article-title":"The revised American Fertility Society classification of endometriosis: reproducibility of scoring. ZOLADEX endometriosis study group","volume":"63","author":"Rock","year":"1995","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2013.03.002_bib0075","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1477-7827-1-108","article-title":"Sperm preparation for ART","volume":"1","author":"Henkel","year":"2003","journal-title":"Reproductive Biology and Endocrinology"},{"key":"10.1016\/j.ejogrb.2013.03.002_bib0080","first-page":"CD003973","article-title":"Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles","author":"Van Wely","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.ejogrb.2013.03.002_bib0085","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.fertnstert.2004.04.026","article-title":"Recombinant versus urinary follicle-stimulating hormone in intrauterine insemination cycles: a prospective, randomized analysis of cost effectiveness","volume":"82","author":"Gerli","year":"2004","journal-title":"Fertility and Sterility"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211513001152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211513001152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:30:46Z","timestamp":1759555846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211513001152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0301211513001152"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2013.03.002","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advantages of recombinant follicle-stimulating hormone over human menopausal gonadotropin for ovarian stimulation in intrauterine insemination: a randomized clinical trial in unexplained infertility","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2013.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}